Condensed Consolidated Statement of Noncontrolling Interests and Equity - USD ($) $ in Thousands	Total	Redemption of Operating Partnership units for stock	Redemption of Operating Partnership units for cash	Noncontrolling Interest - Preferred Operating Partnership	Noncontrolling Interest - Operating Partnership	Noncontrolling Interest - Operating Partnership Redemption of Operating Partnership units for stock	Noncontrolling Interest - Operating Partnership Redemption of Operating Partnership units for cash	Noncontrolling Interest - Other	Common Stock	Common Stock Redemption of Operating Partnership units for stock	Additional Paid-in Capital	Additional Paid-in Capital Redemption of Operating Partnership units for stock	Additional Paid-in Capital Redemption of Operating Partnership units for cash	Accumulated Other Comprehensive Loss	Accumulated Deficit
Balance, beginning of period at Dec. 31, 2019	$ 2,921,694			$ 175,948	$ 205,419			$ 366	$ 1,295		$ 2,868,681			$ (28,966)	$ (301,049)
Balance, beginning of period (in shares) at Dec. 31, 2019									129,534,407
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of options (in shares)									77,400
Issuance of common stock upon the exercise of options	944								$ 1		943
Issuance of common stock in connection with share based compensation (in shares)									73,602
Issuance of common stock in connection with share based compensation	2,980								$ 1		2,979
Restricted stock grants cancelled (in shares)									(1,767)
Buyback of common stock, net of offering costs (in shares)									(653,597)
Buyback of common stock, net of offering costs	(52,204)								$ (7)						(52,197)
Redemption of Operating Partnership units					(330)						330
Redemption of Operating Partnership units for stock (in shares)									8,862
Net income (loss)	116,162			3,112	4,877			(6)							108,179
Other comprehensive income (loss)	(89,244)			(563)	(3,807)									(84,874)
Distributions to Operating Partnership units held by noncontrolling interests	(8,505)			(3,178)	(5,327)
Dividends paid on common stock	(117,197)														(117,197)
Balance, end of period at Mar. 31, 2020	2,774,630			175,319	200,832			360	$ 1,290		2,872,933			(113,840)	(362,264)
Balance, end of period (in shares) at Mar. 31, 2020									129,038,907
Balance, beginning of period at Dec. 31, 2019	2,921,694			175,948	205,419			366	$ 1,295		2,868,681			(28,966)	(301,049)
Balance, beginning of period (in shares) at Dec. 31, 2019									129,534,407
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	227,419
Balance, end of period at Jun. 30, 2020	2,745,518			172,542	196,867			419	$ 1,291		2,884,940			(119,256)	(391,285)
Balance, end of period (in shares) at Jun. 30, 2020									129,069,555
Balance, beginning of period at Mar. 31, 2020	2,774,630			175,319	200,832			360	$ 1,290		2,872,933			(113,840)	(362,264)
Balance, beginning of period (in shares) at Mar. 31, 2020									129,038,907
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of options (in shares)									13,610
Issuance of common stock upon the exercise of options	726										726
Issuance of common stock in connection with share based compensation (in shares)									60,032
Issuance of common stock in connection with share based compensation	4,884								$ 1		4,883
Restricted stock grants cancelled (in shares)									(889)
Buyback of common stock, net of offering costs (in shares)									(172,600)
Buyback of common stock, net of offering costs	(15,615)								$ (1)						(15,614)
Redemption of Operating Partnership units					(3,675)				$ 1		3,674
Redemption of Operating Partnership units for stock (in shares)									100,000
Redemption of Preferred D Units in the Operating Partnership for Stock				(2,724)							2,724
Redemption of Preferred D Units in the Operating Partnership for stock (in shares)									30,495
Noncontrolling interest in consolidated joint venture	68							68
Net income (loss)	111,257			3,139	5,216			(9)							102,911
Other comprehensive income (loss)	(5,728)			(41)	(271)									(5,416)
Distributions to Operating Partnership units held by noncontrolling interests	(8,386)			(3,151)	(5,235)
Dividends paid on common stock	(116,318)														(116,318)
Balance, end of period at Jun. 30, 2020	2,745,518			172,542	196,867			419	$ 1,291		2,884,940			(119,256)	(391,285)
Balance, end of period (in shares) at Jun. 30, 2020									129,069,555
Balance, beginning of period at Dec. 31, 2020	$ 2,936,124			172,052	215,892			401	$ 1,314		3,000,458			(99,093)	(354,900)
Balance, beginning of period (in shares) at Dec. 31, 2020	131,357,961								131,357,961
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of options (in shares)									56,722
Issuance of common stock upon the exercise of options	$ 4,254										4,254
Issuance of common stock in connection with share based compensation (in shares)									89,793
Issuance of common stock in connection with share based compensation	3,652										3,652
Restricted stock grants cancelled (in shares)									(2,499)
Offering costs associated with previous stock issuance	273,720								$ 22		273,698				0
Issuance of common stock, net of offering costs (in shares)									2,185,685
Redemption of Operating Partnership units					(193)						193
Redemption of Operating Partnership units for stock (in shares)									5,000
Noncontrolling interest in consolidated joint venture	(50)							(50)
Net income (loss)	215,501			3,680	8,828			(5)							202,998
Other comprehensive income (loss)	23,013			144	956									21,913
Distributions to Operating Partnership units held by noncontrolling interests	(9,025)			(3,224)	(5,801)
Dividends paid on common stock	(132,540)														(132,540)
Balance, end of period at Mar. 31, 2021	3,314,649			172,652	219,682			346	$ 1,336		3,282,255			(77,180)	(284,442)
Balance, end of period (in shares) at Mar. 31, 2021									133,692,662
Balance, beginning of period at Dec. 31, 2020	$ 2,936,124			172,052	215,892			401	$ 1,314		3,000,458			(99,093)	(354,900)
Balance, beginning of period (in shares) at Dec. 31, 2020	131,357,961								131,357,961
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Buyback of common stock, net of offering costs (in shares)	0
Net income (loss)	$ 394,080
Balance, end of period at Jun. 30, 2021	$ 3,360,955			172,902	219,466			499	$ 1,337		3,288,852			(71,830)	(250,271)
Balance, end of period (in shares) at Jun. 30, 2021	133,791,109								133,791,109
Balance, beginning of period at Mar. 31, 2021	$ 3,314,649			172,652	219,682			346	$ 1,336		3,282,255			(77,180)	(284,442)
Balance, beginning of period (in shares) at Mar. 31, 2021									133,692,662
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with share based compensation (in shares)									44,990
Issuance of common stock in connection with share based compensation	4,983										4,983
Restricted stock grants cancelled (in shares)									(4,972)
Offering costs associated with previous stock issuance	(211)										(211)
Redemption of Operating Partnership units		$ 0	$ (472)			$ (2,185)	$ (113)			$ 1		$ 2,184	$ (359)
Redemption of Operating Partnership units for stock (in shares)										58,429
Repayment of receivable with Operating Partnership units pledged as collateral	411				411
Noncontrolling interest in consolidated joint venture	150							150
Net income (loss)	178,579			3,438	7,190			3							167,948
Other comprehensive income (loss)	5,617			35	232									5,350
Distributions to Operating Partnership units held by noncontrolling interests	(8,974)			(3,223)	(5,751)
Dividends paid on common stock	(133,777)														(133,777)
Balance, end of period at Jun. 30, 2021	$ 3,360,955			$ 172,902	$ 219,466			$ 499	$ 1,337		$ 3,288,852			$ (71,830)	$ (250,271)
Balance, end of period (in shares) at Jun. 30, 2021	133,791,109								133,791,109